InsidersTradesSigma
Follow the 엠젠솔루션 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 엠젠솔루션 has published 7 reports. Market capitalisation: €23.9bn. The latest transaction was reported on 10 July 2026 (Sale). Among the most active insiders: 최은경. Every trade is openly available.
7
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
4 ops.
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,352 of 28,684 companies
7.8
score / 100
Value7
Quality9
FCF yld-21%
Earn yld-70%
EV/EBITDA·
ROE-48%
Gross mgn15%
Net mgn-57%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 July 2026
Declarations7 total
2,320,740 sharesKRXDART:20260701000658
7 of 7 declarations
关于 엠젠솔루션
엠젠솔루션是一家在XKRX市场上市的医疗保健和制药公司。它专注于为医疗领域开发创新解决方案。